Unresectable pancreatic adenocarcinoma with complete clinical response following chemoradiotherapy


AKSOY E., Ulaş M., Çolakoʇlu M. K., Özer I., BOSTANCI E. B., Akoʇlu M.

Turkish Journal of Surgery, cilt.31, sa.1, ss.49-51, 2015 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5152/ucd.2014.2210
  • Dergi Adı: Turkish Journal of Surgery
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.49-51
  • Anahtar Kelimeler: Pancreas, adenocarcinoma, resectability, chemotherapy
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Locally advanced or metastatic disease is present in 2/3s of patients with pancreatic cancer. Pancreatic cancer patients are assessed as resectable, potentially resectable (borderline) and unresectable according to pre-operative examinations. The chance for operability may be enhanced by using adjuvant-neoadjuvant systemic chemotherapy, radiotherapy or both. The rates of R0 resection may be increased by means of treatment delivered this way. This case report presents a pancreatic adenocarcinoma case that was assessed to be resectable but was identified to be unre-sectable during surgical exploration, thus received adjuvant chemoradiotherapy. The patient was then re-evaluated, identified as resectable and received pancreaticoduodenectomy.